|
Inform your business decisions - authoritative
market research - reliable forecasts Learn more about our industry study - purchase by the page or the full report: Study #: 2622 Published: 06/2010 Pages: 351 Full Study Price: US$ 4,800 Per Page Price: US$ 35.00 (text) | 60.00 (table) Nanotechnology in Health Care to 2014 - Market Research, Market Share, Market Size, Sales, Demand Forecast, Market Leaders, Company Profiles, Industry Trends US demand for nanosized medical products will grow 17.1 percent annually through 2014. Cancer and central nervous system disorders will be the fastest growing applications. Nanomedicines will provide the best opportunities, while nanotech medical supplies and devices grow the fastest from a small base. This study analyzes the $34.2 billion US nanotechnology medical product industry. It presents historical demand data for the years 1999, 2004 and 2009, and forecasts for 2014 and 2019 by product (nanomedicines, nanodiagnostics, nanotechnology medical supplies and devices) and application (e.g., wound management products, bone substitutes, dental products, surgical supplies and devices, medical implants). The study also considers market environment factors, details industry structure, evaluates company market share and profiles 56 industry participants, including Roche, Abbott Laboratories and Johnson and Johnson.
TABLE OF CONTENTS
SECTION PAGE
Introduction xii
I. Executive Summary 1
II. Market Environment 4
General 4
Macroeconomic Trends 5
Demographic Patterns 8
Trends in Health Care 11
Health Insurance & Reimbursement 12
Medical Conditions 14
Chronic Conditions 15
Acute Conditions 18
National Health Expenditures 20
Medical Facilities & Professionals 24
Acute Care Hospitals 25
Physicians 25
Outpatient Facilities 26
Skilled Nursing Homes 26
Dentists 27
Patient Activity 27
Hospital Activity 29
Surgical Procedures 29
Outpatient Activity 30
Diagnostic Tests 31
Medical Products Market Outlook 32
Pharmaceuticals & Biologicals 34
Surgical Appliances & Supplies 36
Surgical & Medical Instruments 36
Electromedical Equipment 37
Diagnostic Products 37
Other Medical Products 38
III. Medical Nanomaterials 39
General 39
Monoclonal Antibodies 41
Drug Nanoparticles 43
DNA Materials 45
Quantum Dots 47
Other Medical Nanomaterials 49
Commercialized Materials 49
Dendrimers 50
Fullerenes 51
Nanotubes & Nanowires 53
IV. Nanotechnology Health Care Overview 54
General 54
Product Applications 55
Regulation 59
Pharmaceuticals 59
Diagnostic Products 60
Medical Supplies & Devices 61
Current Good Manufacturing Processes 62
Investment 63
US Trade Opportunities 65
International Activities 66
V. Nanomedicines 72
General 72
Monoclonal Antibodies 75
Types of Monoclonal Antibodies 77
Marketed Products 79
Developmental Activities 96
Nanopolymer Medicines 102
Marketed Products 103
PEG-Based Nanomedicines 104
Other Nanopolymer Medicines 107
Developmental Activities 109
Crystalline Nanomedicines 111
Marketed Products 112
Developmental Activities 115
Liposomal Nanomedicines 115
Marketed Products 117
Developmental Activities 118
Other Nanomedicines 119
Marketed Products 121
Developmental Activities 122
VI. Nanodiagnostics 124
General 124
In Vitro Nanodiagnostics 126
Monoclonal Antibody-Based Nanodiagnostics 128
Immunological Reagents 129
Cellular Analysis Reagents 133
Immunohematology Reagents 134
Research Reagents 136
DNA-Based Nanodiagnostics 137
Amplified DNA Probes 139
Direct DNA Probes 141
DNA Microarrays 142
Other DNA-Based Nanodiagnostics 145
In Vivo Nanodiagnostics 150
MRI Imaging Agents 151
Marketed Products 152
Developmental Products 154
Other In Vivo Nanodiagnostics 155
VII. Nanotechnology Medical Supplies
& Devices 157
General 157
Wound Management Products 160
Wound Dressings 161
Wound Closures 164
Bone Substitutes 165
Dental Products 168
Product Groups 169
Suppliers 170
Surgical Supplies & Devices 171
Surgical Textiles 172
Surgical Devices 173
Medical Implants 174
Orthopedic Implants 175
Cardiac Implants 178
Cochlear Implants 179
Other Medical Implants 180
Ophthalmic Products 182
Nanocoated Lenses 183
Drug Delivery Systems 184
Retinal Implants 184
Other Nanotechnology Medical Supplies & Devices 185
Catheters & Related Devices 186
Disinfectants 187
Artificial Skin 188
VIII. Applications 190
General 190
Cancer 193
Epidemiological Trends 194
Nanomedicines 195
Nanodiagnostics 197
Nanotechnology Medical Supplies & Devices 199
Central Nervous System Conditions 199
Epidemiological Trends 200
Nanomedicines 201
Nanodiagnostics 202
Nanotechnology Medical Supplies & Devices 202
Infective Conditions 203
Epidemiological Trends 205
Nanomedicines 206
Nanodiagnostics 207
Nanotechnology Medical Supplies & Devices 208
Cardiovascular Conditions 208
Epidemiological Trends 209
Nanomedicines 210
Nanodiagnostics 210
Nanotechnology Medical Supplies & Devices 211
Other Applications 212
Ophthalmic Conditions 213
Medical Research & Drug Discovery 214
Respiratory Conditions 215
Endocrine Conditions 215
Gastrointestinal Conditions 215
Dermatological Conditions 216
All Other Applications 216
IX. Industry Structure 218
General 218
Market Share 220
Competitive Strategies 223
Licensing Agreements 225
Mergers & Acquisitions 231
Research & Development 235
Marketing & Distribution 237
Manufacturing 238
Company Profiles 239
Abbott Laboratories 240
Abraxis BioScience Incorporated 244
Access Pharmaceuticals Incorporated 246
Advion BioSciences Incorporated 247
Alexion Pharmaceuticals Incorporated 248
AMAG Pharmaceuticals Incorporated 249
Amgen Incorporated 250
Arrowhead Research Corporation 252
AstraZeneca plc 255
Bayer AG 257
BIOCIUS Life Sciences Incorporated 259
Biogen Idec Incorporated 260
Biophan Technologies Incorporated 262
BioTrove, see Life Technologies
Bristol-Myers Squibb Company 263
Calando Pharmaceuticals, see Arrowhead Research
Centocor Ortho Biotech Products, see Johnson & Johnson
Covidien plc 266
CritiTech Incorporated 267
Crystalplex Corporation 268
CytImmune Sciences Incorporated 269
Danaher Corporation 270
Dendritic Nanotechnologies, see Starpharma Holdings
Elan Corporation plc 271
Enzon Pharmaceuticals Incorporated 275
Flamel Technologies SA 278
Genentech, see Roche Holding
GlaxoSmithKline plc 280
ImClone Systems, see Lilly (Eli) and Company
Intradigm, see Silence Therapeutics
Johnson & Johnson 282
Kerr, see Danaher
Life Technologies Corporation 287
Lilly (Eli) and Company 290
Luna Innovations Incorporated 292
Merck & Company Incorporated 294
Mersana Therapeutics Incorporated 296
NanoBio Corporation 297
Nanobiotix SA 298
NanoCarrier Company Limited 299
NanoDel Technologies GmbH 300
NanoHorizons Incorporated 300
NanoInk Incorporated 301
NanoLab Incorporated 302
Nanospectra Biosciences Incorporated 303
Nanosys Incorporated 304
Nektar Therapeutics Incorporated 305
Novagali Pharma SA 309
Novartis AG 310
Novavax Incorporated 312
Orthovita Incorporated 313
Oxonica plc 314
Pfizer Incorporated 315
Pioneer Surgical Technology Incorporated 319
pSivida Corporation 320
Roche Holding Limited 321
Salvona Technologies Incorporated 329
Schering-Plough, see Merck & Company
Sensatex Incorporated 330
Siemens AG 331
SkyePharma plc 333
Smith & Nephew plc 334
Soliqs, see Abbott Laboratories
Spectrum Pharmaceuticals Incorporated 336
Starpharma Holdings Limited 338
Tego Biosciences, see Arrowhead Research
Teva Pharmaceutical Industries Limited 339
3M Company 340
Wyeth, see Pfizer
Other Companies Mentioned in the Study 341
LIST OF TABLES
TABLE NUMBER PAGE
SECTION I -- Executive Summary
Summary Table 3
SECTION II -- Market Environment
1 Macroeconomic Indicators 8
2 Resident Population by Age Group 11
3 Health Insurance Coverage of the US Population 14
4 Chronic Conditions by Type 18
5 Acute Conditions by Type 20
6 National Health Expenditures 23
7 Selected Medical Facilities & Professionals by Type 24
8 Patient Activity by Type 28
9 Medical Products Demand by Group 33
SECTION III -- Medical Nanomaterials
1 Medical Nanomaterials Demand by Type 40
SECTION IV -- Nanotechnology Health Care Overview
1 Nanotechnology Medical Products Demand by Group 58
2 US Trade in Nanotechnology Medical Products 66
3 World Demand for Nanotechnology Medical Products
by Region 68
SECTION V -- Nanomedicines
1 Nanomedicines Demand by Product Group 74
2 Monoclonal Antibody Nanomedicines Demand by Indication 77
3 Therapeutic Monoclonal Antibodies Approved for US Sale 80
4 US Sales of Selected Therapeutic Monoclonal Antibodies,
2004 & 2009 95
5 Nanopolymer Medicines Demand by Indication 103
6 Polymer Nanomedicines Approved for US Sale 104
7 US Sales of Nanopolymer Medicines, 2004 & 2009 108
8 Crystalline Nanomedicines Demand by Indication 112
9 Crystalline Nanomedicines Approved for US Sales 114
10 Liposomal Nanomedicines Demand by Indication 117
11 Other Nanomedicines Demand by Indication 120
SECTION VI -- Nanodiagnostics
1 Nanodiagnostics Demand by Product Group 125
2 In Vitro Nanodiagnostics Demand by Product Group 127
3 Monoclonal Antibody-Based Nanodiagnostics Demand
by Type 129
4 Monoclonal Antibody-Based Immunological Reagents
Demand 130
5 Monoclonal Antibody-Based Cellular Analysis Reagents
Demand 134
6 Monoclonal Antibody Immunohematology Reagents Demand 136
7 Monoclonal Antibody-Based Research Reagents Demand 137
8 DNA-Based Nanodiagnostics Demand by Type 138
9 In Vivo Nanodiagnostics Demand by Product Group 151
SECTION VII -- Nanotechnology Medical
Supplies & Devices
1 Nanotechnology Medical Supplies & Devices Demand
by Product Group 159
2 Nanotechnology Wound Management Products Demand
by Type 161
3 Nanotechnology Bone Substitutes Demand 167
4 Nanotechnology Dental Products Demand by Group 168
5 Nanotechnology Surgical Supplies & Devices Demand 172
6 Nanotechnology Medical Implant Demand by Type 175
7 Nanotechnology Ophthalmic Products 183
8 Other Nanotechnology Medical Supplies & Devices 186
SECTION VIII -- Applications
1 Nanotechnology Medical Products Demand by Application 192
2 Nanotechnology Medical Products Demand
in Cancer Applications 194
3 Nanotechnology Medical Products Demand
in Central Nervous System (CNS) Applications 200
4 Nanotechnology Medical Products Demand
in Infective Condition Applications 205
5 Nanotechnology Medical Products Demand
in Cardiovascular Applications 209
6 Nanotechnology Medical Products Demand
in Other Applications 213
SECTION IX -- Industry Structure
1 US Nanotechnology Medical Product Sales by Company, 2009 219
2 Selected Cooperative Agreements 226
3 Selected Acquisitions & Divestitures 233
LIST OF CHARTS
CHART NUMBER PAGE
SECTION II -- Market Environment
1 Medical Products Demand by Group, 2009 34
SECTION III -- Medical Nanomaterials
1 Medical Nanomaterials Demand by Type, 2009 41
SECTION IV -- Nanotechnology Health Care Overview
1 Nanotechnology Medical Products Demand by Group, 2009 58
SECTION V -- Nanomedicines
1 Nanomedicines Demand by Product Group, 2009 75
SECTION VI -- Nanodiagnostics
1 Nanodiagnostics Demand by Product Group, 2009 126
SECTION VII -- Nanotechnology Medical Supplies & Devices
1 Nanotechnology Medical Supplies & Devices Demand
by Product Group, 2014 160
SECTION VIII -- Applications
1 Nanotechnology Medical Products Demand
by Application, 2009 193
SECTION IX -- Industry Structure
1 Nanotechnology Medical Products Market Share
by Company, 2009 223
You may view the complete table of contents without charge and select individual records for purchase ($35.00 text | $60 table each) or purchase the complete study.
Home About Freedonia Contact Freedonia Search Studies Browse Catalog The Freedonia Group - The First Choice In Industry Research8 © Copyright 2012 The Freedonia Group, Inc.
|